Repurposing disulfiram: targeting Zeb1 to attenuate paraquat-induced pulmonary fibrosis in rats
- 18 September 2025
- journal article
- research article
- Published by Springer Nature in Journal of Molecular Histology
- Vol. 56 (5) , 1-15
Abstract
Pulmonary fibrosis is a fatal condition marked by excessive extracellular matrix deposition and myofibroblast activation, with paraquat (PQ) being a potentKeywords
All Related Versions
Funding Information
- The Vice-Chancellery for Research and Technology of Babol University of Medical Sciences. (IR.MUBABOL.HRI.REC.1398.247)
This publication has 49 references indexed in Scilit:
- Current Findings and Mechanisms of Action of Disulfiram in the Treatment of Alcohol DependencePharmacopsychiatry, 2016
- Disulfiram inhibits TGF-β-induced epithelial-mesenchymal transition and stem-like features in breast cancer via ERK/NF-κB/Snail pathwayOncotarget, 2015
- Connective tissue growth factor stimulates the proliferation, migration and differentiation of lung fibroblasts during paraquat-induced pulmonary fibrosisMolecular Medicine Reports, 2015
- Losartan attenuates paraquat-induced pulmonary fibrosis in ratsHuman & Experimental Toxicology, 2014
- The Preventive Effect of Atorvastatin on Paraquat-Induced Pulmonary Fibrosis in the Rats2014
- Protective effects of naringin against paraquat-induced acute lung injury and pulmonary fibrosis in miceFood and Chemical Toxicology, 2013
- Clinical implication of protease-activated receptor-2 in idiopathic pulmonary fibrosisRespiratory Medicine, 2013
- Disulfiram, an old drug with new potential therapeutic uses for human hematological malignanciesInternational Journal of Cancer, 2012
- Idiopathic pulmonary fibrosisThe Lancet, 2011
- Simple method of estimating severity of pulmonary fibrosis on a numerical scale.Journal of Clinical Pathology, 1988